Azure Pharmaceuticals

Cholesterol, blood pressure products and aspirin are among those featuring in the latest update that says 307 products are now unavailable

Business Today: the best news, analysis and comment from The Irish Times business desk

Impact of crisis should serve as ‘wake-up call’ to policymakers, says Azure Pharmaceuticals

Refusal of strategy to be published this week to address pricing issues for common off-patent therapies likely only to worsen supply issues

Nasal sprays, asthma inhalers and eye drops the latest to experience shortages in Irish market, says Azure Pharma

Surge in demand this winter puts pressure on supplies amid sharp disagreement over long-term impact of pricing

Department of Health insists alternatives are available for all medicines currently affected by supply shortages

Business Today: the best news, analysis and comment from The Irish Times business desk

Authorities insist demand is main factor for winter big medications but generics group says price puts State at supply disadvantage

Cough syrups and effervescent painkillers that are staples of family medicine cabinets are out of stock

Over-the-counter and prescription drugs affected with some facing a three-month delay before supply is restored

Supply problems always relate to the low-cost market, says head of drug manufacturer

Sandra Gannon services supply chain when firms stop investing in off-patent products